Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Adamis Pharmaceuticals Corporation ADMP NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
10/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Il y a eu 50 transactions d'initiés récentes enregistrées pour Adamis Pharmaceuticals Corporation (ADMP), dont 7 achats et 34 ventes. Le total des achats d'initiés s'élève à $190.04K et le total des ventes d'initiés à $426.11K.

Les initiés notables ayant une activité récente comprennent Dorbin John W. Jr., Cohen Seth, Versi Ebrahim. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — ADMP

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2023-10-23 Dorbin John W. Jr. Officer Inconnu - - - -
2023-10-23 Dorbin John W. Jr. General Counsel Attribution de RSU 70,000 $0.58 $40.6K 70,000
2023-10-16 Cohen Seth Officer Inconnu - - - -
2023-10-16 Cohen Seth CFO Attribution de RSU 151,416 $0.60 $91.09K 151,416
2023-09-15 Versi Ebrahim CEO Conversion (Vente) 729 - - 1,212
2023-05-25 Desai Meera J. Director Attribution de RSU 3,138 $2.50 $7.85K 3,138
2023-05-25 Versi Jannine Director Inconnu - - - -
2023-05-25 Versi Jannine Director Attribution de RSU 1,941 - - 1,941
2023-05-25 Versi Ebrahim CEO Inconnu - - - -
2023-05-25 Versi Ebrahim CEO Attribution de RSU 1,941 - - 1,941
2022-11-14 Birndorf Howard C Director Restitution d'Actions 58,824 - - -
2022-05-25 Carlo Dennis J Phd Other: Former President & CEO Exercice d'Options (Vente) 250,000 - - -
2022-05-24 Reed Vickie S Director Inconnu - - - -
2022-05-24 Reed Vickie S Director Attribution de RSU 50,000 - - 50,000
2022-03-18 Carlo Dennis J Phd President & CEO Vente Informative 10,490 $0.60 $6.29K 285,867
2022-03-18 Marguglio David J. SVP and Chief Business Officer Vente Informative 11,859 $0.60 $7.12K 233,906
2022-03-18 Moss Ronald B. Chief Medical Officer Vente Informative 8,199 $0.60 $4.95K 201,911
2022-03-18 Benedicto David C. Chief Financial Officer Vente Informative 3,603 $0.61 $2.21K 39,875
2021-12-31 Marguglio David J. SVP of Bus. Dev & Cbo Inconnu - - - 5,884
2021-12-01 Carlo Dennis J Phd President & CEO Vente Informative 47,870 $0.79 $37.58K 296,357
2021-12-01 Marguglio David J. SVP and Chief Business Officer Vente Informative 50,757 $0.79 $39.84K 258,765
2021-12-01 Moss Ronald B. Chief Medical Officer Vente Informative 35,553 $0.79 $27.91K 210,110
2021-12-01 Benedicto David C. Chief Financial Officer Vente Informative 13,554 $0.79 $10.64K 43,478
2021-10-01 Desai Meera J. Director Inconnu - - - -
2021-10-01 Desai Meera J. Director Attribution de RSU 50,000 $1.01 $50.5K 50,000
2021-05-23 Benedicto David C. Principal Accounting Officer Cession 51,000 $3.15 $160.65K -
2021-02-21 Carlo Dennis J Phd President & CEO Exercice d'Options (Vente) 27,822 - - -
2021-02-21 Hopkins Robert O Chief Financial Officer Exercice d'Options (Vente) 22,258 - - -
2021-02-21 Marguglio David J. SVP and Chief Business Officer Exercice d'Options (Vente) 22,258 - - -
2021-02-21 Moss Ronald B. Chief Medical Officer Exercice d'Options (Vente) 13,911 - - -
2020-12-31 Carlo Dennis J Phd President & CEO Inconnu - - - 5,883
2020-12-31 Marguglio David J. SVP and Chief Business Officer Inconnu - - - 5,884
2020-11-20 Hopkins Robert O Chief Financial Officer Vente Informative 35,000 $0.41 $14.18K 254,810
2020-11-20 Marguglio David J. SVP and Chief Business Officer Vente Informative 35,000 $0.40 $14K 287,264
2020-11-18 Carlo Dennis J Phd President & CEO Vente Informative 10,665 $0.41 $4.33K 316,405
2020-11-18 Hopkins Robert O Chief Financial Officer Vente Informative 7,229 $0.41 $2.94K 289,810
2020-11-18 Marguglio David J. SVP and Chief Business Officer Vente Informative 8,532 $0.41 $3.46K 322,264
2020-11-18 Daniels Karen K. VP of Operations Vente Informative 5,333 $0.41 $2.17K 149,242
2020-11-18 Moss Ronald B. Chief Medical Officer Vente Informative 8,532 $0.41 $3.46K 231,752
2020-09-29 Hopkins Robert O Chief Financial Officer Vente Informative 20,000 $0.80 $16K 274,781
2020-09-29 Marguglio David J. SVP and Chief Business Officer Vente Informative 20,000 $0.80 $16K 308,539
2020-08-18 Carlo Dennis J Phd President & CEO Vente Informative 10,929 $0.87 $9.55K 299,247
2020-08-18 Hopkins Robert O Chief Financial Officer Vente Informative 7,418 $0.87 $6.48K 294,781
2020-08-18 Marguglio David J. SVP and Chief Business Officer Vente Informative 8,749 $0.87 $7.65K 328,539
2020-08-18 Daniels Karen K. VP of Operations Vente Informative 5,480 $0.87 $4.79K 140,664
2020-08-18 Moss Ronald B. Chief Medical Officer Vente Informative 8,749 $0.87 $7.65K 226,373
2020-05-19 Daniels Karen K. VP of Operations Vente Informative 4,855 $0.56 $2.72K 146,144
2020-05-18 Carlo Dennis J Phd President & CEO Vente Informative 9,913 $0.56 $5.55K 310,176
2020-05-18 Hopkins Robert O Chief Financial Officer Vente Informative 6,532 $0.56 $3.66K 302,199
2020-05-18 Marguglio David J. SVP and Chief Business Officer Vente Informative 7,734 $0.56 $4.33K 337,288
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message